Puretech receives fda fast track designation for lyt-200 in acute myeloid leukemia (aml)

Boston--(business wire)--puretech receives fda fast track designation for lyt-200 in acute myeloid leukemia (aml).
PRTC Ratings Summary
PRTC Quant Ranking